Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.

Abstract

BACKGROUND:

Keloid scarring is a dermal fibroproliferative disorder characterized by increased fibroblast proliferation and excessive production of collagen and extracellular matrix (ECM) components. To date, the role of cytokines in keloid pathogenesis has not been completely unravelled. Interleukin (IL)-18 is a pro-inflammatory cytokine that plays important roles in wound healing, fibrogenesis and carcinogenesis.

OBJECTIVES:

Our aim was to study the role of the IL-18 system in keloid pathogenesis.

MATERIALS AND METHODS:

Expression and localization of IL-18 and its receptor (IL-18R) were investigated in normal skin and keloid tissues using Western blot and immunohistochemistry. We further studied the expression of the IL-18 system in normal and keloid-derived cell lines in a coculture model.

RESULTS:

Results from Western blot and immunohistochemistry revealed that IL-18, IL-18Rα and IL-18Rβ expression was elevated in keloid tissue compared with normal skin tissue. Studies on the expression of IL-18 and its antagonist, IL-18 binding protein (IL-18BP), using a coculture model demonstrated severe IL-18/IL-18BP imbalance in keloid keratinocyte/keloid fibroblast (KK/KF) cocultures with significant elevation of bioactive IL-18 whereas IL-18BP levels remained the same. This overproduction of bioactive IL-18 in keloid cocultures could be due to increased caspase-1 and decreased caspase-3 expression in keloid tissue, as well as decreased soluble IL-10 levels observed in keloid cocultures. The important inductive effects of IL-18 on KFs were further underscored by the observation that exposure of KF to IL-18 resulted in increased collagen and ECM component synthesis, and increased secretion of profibrotic cytokines such as IL-6 and IL-8. Finally, the addition of phosphatidylinositol 3-kinase (PI3K), mitogen activation protein kinase (MAPK), specificity protein 1 (Sp1) and mammalian target of rapamycin (mTOR) inhibitors inhibited IL-18 secretion in keloid cocultures.

CONCLUSIONS:

The present study has proven that the IL-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. It also suggests a therapeutic potential of PI3K, MAPK, Sp1 and mTOR inhibitors in the treatment of keloid scarring.

• Authors: D V Do, C T Ong, Y T Khoo, A Carbone, C P Lim, S Wang, A Mukhopadhyay, X Cao, D H Cho, X Q Wei, G Bellone, I Lim, T T Phan
• Journal: The British journal of dermatology (Br J Dermatol) Vol. 166 Issue 6 Pg. 1275-88 (Jun 2012) ISSN: 1365-2133 [Electronic] England
• PMID: 22050194 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2012 The Authors. BJD © 2012 British Association of Dermatologists 2012.

Chemical References

• Enzyme Inhibitors
• Interleukin-18
• Interleukin-6
• Interleukin-8
• Receptors, Interleukin-18
• Sp1 Transcription Factor
• Collagen
• MTOR protein, human
• TOR Serine-Threonine Kinases
• Mitogen-Activated Protein Kinase Kinases
• Caspase 3
• Caspase 1

Topics

• Caspase 1 (metabolism)
• Caspase 3 (metabolism)
• Cells, Cultured
• Collagen (metabolism)
• Enzyme Inhibitors (pharmacology)
• Epithelial-Mesenchymal Transition (physiology)
• Fibroblasts (drug effects, metabolism)
• Humans
• Interleukin-18 (pharmacology, physiology)
• Interleukin-6 (metabolism)
• Interleukin-8 (metabolism)
• Keloid (etiology)
• Keratinocytes (drug effects, metabolism)
• Mitogen-Activated Protein Kinase Kinases (metabolism)
• Phosphatidylinositol 3-Kinases (metabolism)
• Receptors, Interleukin-18 (metabolism)
• Sp1 Transcription Factor (metabolism)
• TOR Serine-Threonine Kinases (metabolism)